https://www.selleckchem.com/products/ubcs039.html
03; =0.046 [stable CAD] and OR, 1.05; =0.01 [ACS]). The mean statin dosage (atorvastatin equivalent) was 17 mg/day. In the 79 ACS patients who underwent the follow-up examination, the LDL-C under target rate rose to 59.5%. Only a minority of patients with stable CAD or ACS were under their target LDL-C level at enrollment. The statin dose was not sufficient in the majority of patients. These results indicate a considerable LLT gap in Korean patients with established CAD. Only a minority of patients with stable CAD or ACS were under thei
Like
Comment
Share
